Skip to main content

Table 1 Effects of genotype and drug on [3H]DA uptake and DAT density

From: Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor

   

[3H]DA uptake

DAT density

 

Group

N

Vmax

SD

Km

SD

DAT

SD

WT w Veh

4

516.1

± 56.5

56.7

± 18.6

10.6

± 2.5

D3 KO w Veh

4

212.4

± 18.2

10.8

± 5.7

10.8

± 1.5

WT w PPX

6

183.4

± 34.3

28.4

± 18.5

9.9

± 3.0

D3 KO w PPX

6

223.6

± 36.4

10.4

± 10.9

9.4

± 2.6

  1. Wild-type and D3 KO mice were administered vehicle (0.9% saline) or pramipexole (PPX, 0.1 mg/kg I.P.) once a day for 5 days. Twenty-four hours after the last injection the brains were removed, the CPu dissected and fresh frozen ([3H]DA uptake) or brains frozen on dry-ice ([125I] RTI-55 autoradiography).
  2. [3H]DA uptake Vmax reported as pmol/mg P/5 min and Km reported as nM. [125I] RTI-55 autoradiography for DAT density reported as fmol/μg P.